1-8 of 8
Mingyi Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

Shakur Mohibi, Jin Zhang, Mingyi Chen, Xinbin Chen
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 830.
https://doi.org/10.1158/1538-7445.AM2022-830
Published: 15 June 2022
View article titled, Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression
Journal Articles

Abstract 882: A novel p73 C-terminal isoform, p73α1, regulates inflammation and tumor suppression via the Notch1 pathway

Kyra Laubach, Wenshen Yan, Xiangmudong Kong, Mingyi Chen, Jin Zhang, Xinbin Chen
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 882.
https://doi.org/10.1158/1538-7445.AM2022-882
Published: 15 June 2022
View article titled, Abstract 882: A novel p73 C-terminal isoform, p73α1, regulates inflammation and tumor suppression via the Notch1 pathway
Journal Articles

Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression

Christopher A. Lucchesi, Jin Zhang, Buyong Ma, Mingyi Chen, Xinbin Chen
Journal: Cancer Research
Cancer Res (2019) 79 (4): 807–818.
https://doi.org/10.1158/0008-5472.CAN-18-2209
Published: 15 February 2019
View article titled, Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression
Open the PDF for Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression in another window
Includes: Supplementary data
Journal Articles

Abstract 2981: Clonal deletion of tumor-specific T cells by combination checkpoint blockade compromises antitumor efficacy in low tumor burden states

Chien-Chun Steven Pai, Xiaoqing Lu, Donald Simons, Michel DuPage, Kole T. Roybal, Mingyi Chen, Serena Kwek, Amy-Jo Casbon, Gillian A. Kinsbury, Lawrence Fong
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2981.
https://doi.org/10.1158/1538-7445.AM2018-2981
Published: 01 July 2018
View article titled, Abstract 2981: Clonal deletion of tumor-specific T cells by combination checkpoint blockade compromises antitumor efficacy in low tumor burden states
Journal Articles

Abstract 2988: Loss of Rbm38 cooperates with mutant p53 to promote lymphomagenesis through downregulation of Pten

Jin Zhang, Heejung yang, Yanhong Zhang, Mingyi Chen, Xinbin Chen
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2988.
https://doi.org/10.1158/1538-7445.AM2018-2988
Published: 01 July 2018
View article titled, Abstract 2988: Loss of Rbm38 cooperates with mutant p53 to promote lymphomagenesis through downregulation of Pten
Journal Articles

Genetic Ablation of Rbm38 Promotes Lymphomagenesis in the Context of Mutant p53 by Downregulating PTEN

Jin Zhang, Enshun Xu, Cong Ren, Hee Jung Yang, Yanhong Zhang, Wenqiang Sun, Xiangmudong Kong, Weici Zhang, Mingyi Chen, Eric Huang, Xinbin Chen
Journal: Cancer Research
Cancer Res (2018) 78 (6): 1511–1521.
https://doi.org/10.1158/0008-5472.CAN-17-2457
Published: 14 March 2018
View article titled, Genetic Ablation of <em>Rbm38</em> Promotes Lymphomagenesis in the Context of Mutant p53 by Downregulating PTEN
Open the PDF for Genetic Ablation of <em>Rbm38</em> Promotes Lymphomagenesis in the Context of Mutant p53 by Downregulating PTEN in another window
Includes: Supplementary data
Journal Articles

Abstract LB-021: LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of triple-negative/basal-B breast cancer cells

Nucharee Yokdang, Jason Hatakeyama, Jessica Wald, Catalina Simion, Joseph Tellez, Dennis Chang, Manojit Swamynathan, Mingyi Chen, William Murphy, Kermit Carraway, Colleen Sweeney
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-021.
https://doi.org/10.1158/1538-7445.AM2016-LB-021
Published: 15 July 2016
View article titled, Abstract LB-021: LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of triple-negative/basal-B breast cancer cells
Journal Articles

Abstract 1929: Tyrosine kinase inhibition with sorafenib but not pazopanib enriches for sarcoma cancer stem cells in diverse models of soft tissue sarcoma

Robert J. Canter, Erik Ames, Stephanie Mac, Steve K. Grossenbacher, Mingyi Chen, Joe Tellez, Arta M. Monjazeb, William J. Murphy
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1929.
https://doi.org/10.1158/1538-7445.AM2014-1929
Published: 01 October 2014
View article titled, Abstract 1929: Tyrosine kinase inhibition with sorafenib but not pazopanib enriches for sarcoma cancer stem cells in diverse models of soft tissue sarcoma